Search research articles
Contact Us
Filters
Showing results (41-50 of 208) with videos related to
Page
of 21
Sort By:
Expert Review of Clinical Pharmacology
|
March 31, 2026
PD-1/PD-L1 for prostate cancer: from clinical trials to practice
Aaron Holmes, Tobechukwu Okobi, Abdul Baseet Arham, et al.
Urologic Oncology
|
July 7, 2023
Antibody-drug conjugates for urothelial carcinoma
Joseph Thomas, Michael Sun, Ted Getz, et al.
Physical Biology
|
February 15, 2019
Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients
Daniel Worroll, Giuseppe Galletti, Ada Gjyrezi, et al.
Urologic Oncology
|
August 1, 2021
A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer
Piyush K Agarwal, John P Sfakianos, Adam Feldman, et al.
European Urology
|
April 9, 2023
Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022
Michael J Morris, Oliver Sartor, Johann S de Bono, et al.
Oncotargets and Therapy
|
December 16, 2014
Microtubule inhibitor-based antibody-drug conjugates for cancer therapy
Kelsey Klute, Eleni Nackos, Shinsuke Tasaki, et al.
Urologic Oncology
|
June 5, 2012
Prostate-specific membrane antigen-based imaging
Joseph R Osborne, Naveed H Akhtar, Shankar Vallabhajosula, et al.
Molecular Diagnosis & Therapy
|
May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential
Giuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Journal of Oncology Practice
|
April 10, 2019
Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis
Panagiotis J Vlachostergios, Julia T Geyer, John Miller, et al.
Expert Opinion on Biological Therapy
|
November 8, 2016
Antibody therapeutics for treating prostate cancer: where are we now and what comes next?
Panagiotis J Vlachostergios, Giuseppe Galletti, Jessica Palmer, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 208) with videos related to
Sort By:
Page
of 21
Expert Review of Clinical Pharmacology
|
March 31, 2026
PD-1/PD-L1 for prostate cancer: from clinical trials to practice
Aaron Holmes, Tobechukwu Okobi, Abdul Baseet Arham, et al.
Urologic Oncology
|
July 7, 2023
Antibody-drug conjugates for urothelial carcinoma
Joseph Thomas, Michael Sun, Ted Getz, et al.
Physical Biology
|
February 15, 2019
Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients
Daniel Worroll, Giuseppe Galletti, Ada Gjyrezi, et al.
Urologic Oncology
|
August 1, 2021
A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer
Piyush K Agarwal, John P Sfakianos, Adam Feldman, et al.
European Urology
|
April 9, 2023
Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022
Michael J Morris, Oliver Sartor, Johann S de Bono, et al.
Oncotargets and Therapy
|
December 16, 2014
Microtubule inhibitor-based antibody-drug conjugates for cancer therapy
Kelsey Klute, Eleni Nackos, Shinsuke Tasaki, et al.
Urologic Oncology
|
June 5, 2012
Prostate-specific membrane antigen-based imaging
Joseph R Osborne, Naveed H Akhtar, Shankar Vallabhajosula, et al.
Molecular Diagnosis & Therapy
|
May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential
Giuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Journal of Oncology Practice
|
April 10, 2019
Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis
Panagiotis J Vlachostergios, Julia T Geyer, John Miller, et al.
Expert Opinion on Biological Therapy
|
November 8, 2016
Antibody therapeutics for treating prostate cancer: where are we now and what comes next?
Panagiotis J Vlachostergios, Giuseppe Galletti, Jessica Palmer, et al.
Page
of 21